Packages

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

Quality control of Tc-99m MAA, particle size and count, suspension stability, lung perfusion studies, lung-shunt estimation, pre-therapy dosimetry and concordance with Y-90 distribution.

Quality control of HIDA, mebrofenin and disofenin, hepatic extraction and gallbladder ejection calculations, and hepatobiliary transit review.

Tc-99m HMPAO leukocyte labelling, labelling efficiency, cell viability and recovery, free activity, process time and temperature, and pre-reinjection release.

Sodium pertechnetate Tc-99m quality control and thyroid, salivary-gland, Meckel diverticulum and ectopic gastric-mucosa imaging workflows.

Tc-99m nanocolloid and tilmanocept control, injection review, acquisition QC, node-detection threshold and shine-through assessment.

In-111 and Tc-99m platelet labelling, cell recovery, autologous-cell release and cell-viability control.

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Macroaggregated albumin: particle size and count, radiochemical purity, resuspension, lung perfusion, lung shunt and pre-therapy Y-90 planning.

Pertechnetate as a standalone radiopharmaceutical and starting material: thyroid uptake, salivary glands, Meckel scan, gastric mucosa and generator/eluate control.

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.